Behcet's disease: Treatment of mucocutaneous lesions

Alpsoy E.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, vol.23, no.4, pp.532-539, 2005 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Review
  • Volume: 23 Issue: 4
  • Publication Date: 2005
  • Journal Name: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.532-539
  • Keywords: Behcet's disease, treatment, review, oral ulcer, genital ulcer, cutaneous lesions, RECURRENT APHTHOUS STOMATITIS, DOUBLE-BLIND TRIAL, TOPICAL ALPHA-INTERFERON, SUCRALFATE SUSPENSION, CLINICAL-TRIAL, ORAL ULCERS, 5-PERCENT AMLEXANOX, ULCERATION, LEVAMISOLE, COLCHICINE
  • Akdeniz University Affiliated: Yes

Abstract

Oral and genital ulcers, and cutaneous vasculitic lesions are considered hallmarks of the disease, and often precede other manifestations. Mucocutaneous lesions figure prominently in the presentation and diagnosis. Therefore, their recognition may permit earlier diagnosis and treatment, with beneficial results for prognosis. This review overviews the current state of knowledge regarding the therapeutic approaches including local and systemic agents for the treatment of mucocutaneous lesions of BD.